Bisphosphonate and estrogen replacement therapy for postmenopausal periodontitis

Israel Medical Association Journal

Volumn 6, Issue 3, 2004, Pages 173-177

  Haimov Kochman, Ronit ^a,c   Kochman, Tuvia ^b   Stabholz, Ayala ^a   Hochner Celinkier, Drorith ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Leumit Research Institue   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biphosphonate; Estrogen replacement therapy; Menopause; Periodontitis

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; PLACEBO; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

DISEASE ASSOCIATION; DOG; ESTROGEN THERAPY; FEMALE; GINGIVITIS; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; MONKEY; MOUTH HYGIENE; NONHUMAN; OSTEOLYSIS; PERIODONTICS; PERIODONTITIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK BENEFIT ANALYSIS; SMOKING CESSATION; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; BONE DENSITY; DIPHOSPHONATES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PERIODONTITIS; POSTMENOPAUSE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1642389399     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. National Institute of Dental Research. Broadening the Scope: Long-Range Research Plan for the Nineties. Bethesda, MD: National Institutes of Health, NIH Publication No. 90-1188, 1990.
2. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996;67(Suppl):1041-9.
3. Friedlander AH. The physiology, medical management and oral implications of menopause. J Am Dent Assoc 2002;133:73-81.
4. Reinhardt RA, Masada MP, Payne JB. Allison AC, DuBois LM. Gingival fluid IL-1 beta and IL-6 levels in menopause. J Clin Periodontol 1994;21:22-5.
5. Groen JJ, Duyvensz F, Halsted JA. Diffuse alveolar atrophy of the jaw (non-inflammatory form of paradental disease) and pre-senile osteoporosis. Geront Clin 1960;2:68-86.
6. Manzke E, Chesnut CH III, Wergedal JE, Baylink DJ, Nelp WB. Relationship between local and total bone mass in osteoporosis. Metabolism 1975;24:605-15.
7. Inagaki K, Kurosu Y, Kamiya T, et al. Low metacarpal bone density, tooth loss, and periodontal disease in Japanese women. J Dent Res 2001;80:1818-22.
8. Payne JB, Reinhardt RA, Nummikoski PV, Dunning DG, Patil KD. The association of cigarette smoking with alveolar bone loss in postmenopausal females. J Clin Periodontol 2000;27:658-64.
9. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 2000;71:1492-8.
10. Taguchi A, Suei Y, Ohtsuka M, Otani K, Tanimoto K, Hollender LG. Relationship between bone mineral density and tooth loss in elderly Japanese women. Dentimaxillofac Radiol 1999;28:219-23.
11. Payne JB, Reinhardt RA, Nummikoski PV, Patil KD. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int 1999;10:34-40.
12. Bando K, Nitta H, Matsubara M, Ishikawa I. Bone mineral density in periodontally health and edentulous postmeopausal women. Ann Periodontol 1998;3:322-6.
13. Streckfus CF, Johnson RB, Nick T, Tsao A, Tucc M. Comparison of alveolar bone loss, alveolar bone density and second metacarpal bone density, salivary and gingival cervicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy. J Gerontol A Biol Sci Med Sci 1997;52:M343-51.
14. Jacobs R, Ghyselen J, Koninckx P, Van Steenberghe D. Long-term bone mass evaluation of mandible and lumbar spine in a group of women receiving hormone replacement therapy. Eur J Oral Sci 1996;104:10-16.
15. Von Wowern N, Klausen B, Kellerup G. Osteoporosis: A risk factor in periodontal disease. J Periodontol 1994;65:1134-8.
16. Klemetti E, Collins HL, Forss H, Markkanen H, Lassila V. Mineral status of skeleton and advanced periodontal disease. J Clin Periodontol 1994;21:184-8.
17. Elders PJM, Habets LLMH, Netelenbos JC, Van den Linden LWJ, Van der Stelt PF. The relation between periodontitis and systemic bone mass in women between 46 and 55 years of age. J Clin Periodontol 1992;19:492-6.
18. Mohajery M, Brook SL. Oral radiograph in the detection of early signs of osteoporosis. Oral Surg Oral Med Oral Pathol 1992;73:112-17.
19. Astrom J, Backstrom C, Thidevall G. Tooth loss and hip fractures in the elderly. J Bone Joint Surg Br 1990;72:324-5.
20. Loza JC, Carpio LC, Dziak R. Osteoporosis and its relationship to oral bone loss. Curr Opin Periodontol 1996;3:27-33.
21. Hildebolt CF. Osteoporosis and oral bone loss. Dentomaxillofac Radiol 1997;26:3-15.
22. Chestnut CH III. The relationship between skeletal and oral bone mineral density: An overview. Ann Periodontol 2001;6:193-6.
23. Grodstein F, Colditz Ga, Stampfer MJ. Post-menopausal hormone use and tooth loss: A prospective study. J Am Dent Assoc 1996;127:370-7, quiz 392.
24. Paganini-Hill A. The benefits of estrogen replacement therapy on oral health. The Leisure World cohort. Arch Intern Med 1995;155:2325-9.
25. Payne JB, Zachs NR, Reinhardt RA, Nummikoski PV, Patil K. The association between estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis. J Periodontol 1997;68:24-31.
26. Jeffcoat MK. Osteoporosis: A possible modifying factor in oral bone loss. Ann Periodontol 1998;3;312-21.
27. Civitelli R, Pilgram TK, Dotson M, et al. Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: A randomized, double-bline, placebo-controlled trial. Arch Intern Med 2002;162:1409-15.
28. Johnson RB, Gilbert JA, Cooper RC, et al. Effect of estrogen deficiency on skeletal and alveolar bone density in sheep. J Periodontol 2002;73:383-91.
29. Reinhardt Ra, Payne JB, Maze C, Patil KD, Gallagher SJ, Mattson JS. Influence of estrogen and osteopenia/osteoporosis on clinical period-ontitis in postmenopausal women. J Periodontol 1999;70:823-8.
30. Reinhardt RA, Payne JB, Maze C, Babbit M, Nummikoski PV, Dunning D. Gingival fluid IL-1 beta in postmenopausal females on supportive periodontal therapy. A longitudinal 2-year study. J Clin Periodontol 1998;25:1029-35.
31. Morishita M, Miyagi M, Iwamoto Y. Effects of sex hormones on production of interleukin-1 by human peripheral monocytes. J Periodontol 1999;70:757-60.
32. Birkenfeld L, Yemini M, Kase NG, Birkenfeld A. Menopause-related oral alveolar bone resorption: A review of relatively unexplored consequences of estrogen deficiency. Menopause 1999;6:129-33.
33. Rossouw JE, Anderson GL, Prentice RL, et al., for the Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
34. Report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy. October, 2002.
35. Brunsvold MA, Chaves ES, Kornman KS, Audfemorte TB, Wood R. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 1992;63:825-30.
36. Weinreb M, Quartuccio H, Seedor JG, et al. Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys. J Periodont Res 1994;29:35-40.
37. Reddy MS, Weatherford TW 3rd, Smith CA, West BD, Jeffcoat MK, Jacks TM. Alendronate treatment of naturally occurring periodontitis in beagle dogs. J Periodontol 1995;66:211-17.
38. Rocha M, Nava LE, Vazquez de la Torre C, Sanchez-Marin F, Garay-Sevilla ME, Malacara JM. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: A randomized, placebo-controlled trial. J Periodontol 2001;72:204-9.